Millennium: The Takeda Oncology Company was founded in 1993 in Cambridge, Massachusetts with a vision for innovation and excellence in science. We evolved from a genomics company, applying world-class recombinant technology to the discovery and development of innovative new therapies, into a fully-integrated biopharmaceutical company with a broad pipeline of promising investigational drug candidates. Millennium was acquired by Takeda Pharmaceuticals in 2008, the largest pharmaceutical company in Japan. Over the years, Millennium has grown to employ more than 1,300 people at our headquarters in Cambridge. Our highest priority is to develop and bring to market new medicines that improve the lives of cancer patients. We have a large pipeline of promising drug candidates fueled by a bold vision to one day cure cancer.

Millennium's mission is to deliver extraordinary medicines to patients with cancer worldwide through our science, innovation, and passion. Our competency begins with drug discovery and clinical development, and continues with critical skills and services essential to making a difference in the lives of people battling cancer. We manufacture and market a life extending cancer therapy derived from Nobel Prize-winning science. Our team includes some of the world's finest thought leaders in protein homeostasis, medicinal chemistry, biology and the clinical sciences. Our commercialization efforts are supported by a team of medical experts who are committed to educating healthcare providers on the safe and efficacious use of our medicines. Our oncology sales specialists have specific expertise well-suited to the needs of clinicians and play a valuable role in the delivery of healthcare.

Find jobs at http://joinmillennium.com/27.